MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Schrödinger Retained Earnings 2011-2026 | SDGR
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Schrödinger
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -629 M | -526 M | -338 M | -379 M | -230 M | -130 M | -105 M | -80.5 M | -52.1 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -52.1 M | -629 M | -274 M |
Quarterly Retained Earnings Schrödinger
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -661 M | -629 M | -585 M | -485 M | -447 M | -393 M | -308 M | -246 M | -250 M | -379 M | -352 M | - | -264 M | -230 M | -199 M | -164 M | -130 M | -130 M | -130 M | -130 M | -130 M | -105 M | -105 M | -105 M | -105 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -105 M | -661 M | -278 M |
Retained Earnings of other stocks in the Health information services industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-372 M | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
-1.1 B | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
6.75 B | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
-2.06 B | $ 5.76 | 0.96 % | $ 92.4 M | USA |
 |
Computer Programs and Systems
CPSI
|
8.13 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
-1.08 B | - | - | $ 2.94 B | USA |
 |
Phreesia
PHR
|
-743 M | $ 11.66 | 3.74 % | $ 636 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-517 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
580 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
301 M | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
-277 M | - | - | $ 102 M | USA |
 |
Teladoc Health
TDOC
|
-16.4 B | $ 5.54 | -0.45 % | $ 976 M | USA |
 |
Evolent Health
EVH
|
-606 M | $ 2.31 | 1.99 % | $ 216 M | USA |
 |
10x Genomics
TXG
|
-1.28 B | $ 20.92 | 0.05 % | $ 2.45 B | USA |
 |
NextGen Healthcare
NXGN
|
129 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
-618 M | - | - | $ 3.37 B | USA |
 |
MTBC
MTBC
|
-55.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
-485 M | - | - | $ 2.33 B | USA |
 |
Zhongchao
ZCMD
|
-7.96 M | $ 1.8 | - | $ 9.37 M |  China |
 |
GoodRx Holdings
GDRX
|
-1.44 B | $ 2.07 | 0.49 % | $ 798 M | USA |
 |
SCWorx Corp.
WORX
|
-31 M | $ 0.13 | 2.64 % | $ 190 K | USA |
 |
Signify Health
SGFY
|
-558 M | - | -0.02 % | $ 7.21 B | USA |
 |
HealthStream
HSTM
|
109 M | $ 21.34 | 0.52 % | $ 648 M | USA |
 |
R1 RCM
RCM
|
-64.3 M | - | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
-67.7 M | - | - | $ 161 M | USA |
 |
Streamline Health Solutions
STRM
|
-126 M | - | - | $ 21.4 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
768 M | - | -10.39 % | $ 886 M | USA |
 |
Health Catalyst
HCAT
|
-1.36 B | $ 1.12 | 1.82 % | $ 78.3 M | USA |
 |
NantHealth
NH
|
-1.12 B | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
196 M | $ 83.56 | 1.32 % | $ 7.2 B | USA |
 |
Omnicell
OMCL
|
383 M | $ 35.08 | 0.39 % | $ 1.62 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-64.3 M | $ 7.19 | 0.14 % | $ 123 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-408 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
144 M | $ 18.14 | 2.2 % | $ 1.56 B | USA |
 |
So-Young International
SY
|
-926 M | $ 3.07 | -3.76 % | $ 244 M | China |
 |
Veeva Systems
VEEV
|
4.36 B | $ 182.14 | 2.28 % | $ 29.8 B | USA |